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The cultivated species of the wild autochthonous Asparagus oﬃcinalis in Andalusia in Spain is commonly called “triguero”
asparagus. This vegetable has traditionally been very much appreciated for its organoleptic and nutritional characteristics. This
study has been designed to evaluate the potential eﬀect of diﬀerent concentrations of freeze-dried asparagus (500, 250, and
125mg/Kg of body weight/day) on oxidative status and lipid profile in rats fed a cholesterol-rich diet. After five weeks of treatment,
doses of 250 and 500mg/Kg of asparagus were able to significantly reduce total cholesterol and LDL cholesterol levels. Atherogenic
index was also significantly reduced in a dose-dependent manner by administrating freeze-dried asparagus. A beneficial eﬀect
was observed in the HDL cholesterol levels in asparagus-fed groups although the increase was not significant. Consumption of
asparagus also improved antioxidant status, assayed superoxide dismutase (SOD) and catalase (CAT) enzymes, and protected
against lipid peroxidation. These results show that the intake of green asparagus from Andalusia (Spain) helps to regulate plasma
lipid levels and prevents oxidative damage in hypercholesterolemic conditions.
1. Introduction
Atherosclerosis is known to be the principal contributor to
the pathogenesis of myocardial and cerebral infarctions, and
these are currently the leading cause of morbidity and mor-
tality worldwide [1]. Hypercholesterolemia, or more specif-
ically elevated plasma total cholesterol and low-density lipo-
protein cholesterol (LDL-c), is an important risk factor
for the development and progression of atherosclerosis [2].
Diet is the first therapeutic approach to treat hyperlipi-
demia. Combination of antioxidants and hypocholestero-
lemic agents in diets is crucial to upset cholesterol levels and
hence to restrict the development of atherosclerotic lesions.
A number of vegetables with potential bioactive components,
such as polyphenols, sterols, and fibre, have been investigated
for their antihyperlipidemic, antioxidant, and antiatheroscle-
rotic properties [3, 4]. Some studies have investigated the
cholesterol-lowering properties and hepatoprotective eﬀect
of asparagus from diﬀerent species and world areas, such as
Asparagus racemosus from India [5] or Asparagus oﬃcinalis
by-products from China [6].
“Triguero” asparagus from Andalusia (Spain) is a prod-
uct traditionally used in Spain, very appreciated for its organ-
oleptic and nutritional characteristics. Although this species
contains an interesting composition in bioactive compo-
nents, it’s functional properties have been poorly studied. It
has been established that, among the most commonly con-
sumed vegetables, green asparagus from Andalusia presents
higher antioxidant capacity [7] than other asparagus from
other world areas, and this property has been associated to
a great extent to its total phenolic content [8]. It has been
demonstrated that the flavonoid rutin represents 60–80%
of the total phenolic content of purple and green asparagus
extracts and that content of rutin could be partially respon-
sible for its antioxidant properties [9].
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Figure 1: Average weekly food intake (g) of rats from SD, HCD and
HCD supplemented with freeze-dried asparagus: 125mg/kg (FA-1);
250mg/kg (FA-2); 500mg/kg (FA-3) groups, during 5-week feeding
period. Each bar represents mean ± SE from six rats. ∗∗P < 0.01;
∗∗∗P < 0.001.
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Figure 2: Average animal weight (g) of rats from SD or HCD and
HCD supplemented with freeze-dried asparagus: 125mg/kg (FA-1);
250mg/kg (FA-2); 500mg/kg (FA-3) groups, during 5-week feeding
period. Each bar represents mean ± SE from six rats.
The aim of the current study was to evaluate the hypo-
cholesterolemic eﬀect of “triguero” asparagus from Andalu-
sia by analyzing its eﬀects on plasma lipid levels and its in-
fluence on the hepatic antioxidant status of rats fed a cho-
lesterol-rich diet.
2. Subjects andMethods
2.1. Plant Material. Cultivated “triguero” asparagus comes
from wild asparagus autochthonous (Asparagus oﬃcinalis)
from the Hue´tor-Ta´jar area (Andalusia, Spain). On harvest
day, asparagus spears were transported to the laboratory and
then weighed, frozen at −20◦C, and freeze-dried. This plant
tissue was ground into a fine powder and stored at−20◦C for
the experiments.
2.2. Animals and Diets. Thirty male Wistar rats, weigh-
ing 100–125 g, purchased from Central Animal House of
Espartinas (Seville, Spain) were housed in an air-conditioned
room at 25 ± 1◦C and 65–70% relative humidity with a
12 h light-dark cycle. The protocol used in this study was
approved by the Ethic Committee for Animal Experimenta-
tion of the University of Seville (Spain), based on the recom-
mendations of the European Council (86/609/EEC). Diets
were made following American Institute of Nutrition (AIN)
recommendations [10]. Animals were randomly assigned to
five groups (n = 6). The first group was fed a standard
diet (Harlan S. L), called SD. The second group was fed
the standard diet supplemented with 1% cholesterol and
0.20% cholic acid, called HCD. Asparagus-treated groups,
received standard diet supplemented with 1% cholesterol,
0.20% cholic acid, and freeze-dried asparagus at doses of
125, 250, and 500mg/kg of animal, respectively, during 5
weeks. These last were named FA-1, FA-2, and FA-3. The
animals were given food and water ad libitum during the
experimental period. Diet intake and the body weight were
weekly recorded.
2.3. Tissue Preparations. At the end of the treatment, the
animals were kept for 24 h fasting, and rats in all groups were
anaesthetized; their blood was drawn by cardiac puncture
and heparinised. Blood samples were centrifuged at a speed
of 4000 g (4min, 4◦C) to obtain the plasma.
The livers were collected, weighed, and latter rinsed with
physiological saline. All samples were stored at −80◦C until
analyzed.
2.4. Plasma Lipid Profiles and Atherogenic Index (AI) Val-
ues. Concentrations of total cholesterol (TC), triglycerides
(TG), and cholesterol high-density lipoprotein (HDL-c) in
plasmawere determined by enzymatic colorimetricmethods,
using commercial kits (Spinreact). Cholesterol low-density
lipoprotein (LDL-c) was accomplished according to the pro-
cedures described by Friedewald et al. [11].The atherosclero-
sis index (AI) was defined as (TC−HDL-c)/HDL-c) and was
calculated for the experimental groups.
2.5. Evaluation of Antioxidant Status. Liver homogenates
(10% w/v) were prepared in 0.25M sucrose, 1mM EDTA,
1mM DL-dithiothreitol, and 15mM Tris-HCl (pH 7.4).
Each homogenate was centrifuged at 800 g for 20min at
4◦. The supernatant was used to determine hepatic enzyme
activities. Catalase activity (CAT) was measured by the
method described by Aebi [12]. Changes in absorbance were
recorded at 240 nm. CAT activity was calculated in terms of
mU/mg protein. Superoxide dismutase (SOD) activity was
estimated using the xanthine-oxidase-cytochrome Cmethod
[13]. The inhibition of xanthine-oxidase was followed spec-
trophotometrically at 550 nm. The activity was expressed
in U/mg of protein. Lipid peroxidation was estimated
according to the method of Esterbauer and Cheeseman [14].
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Figure 3: Changes in plasma lipid levels of rats from SD, HCD, and HCD supplemented with freeze-dried asparagus: 125mg/kg (FA-1);
250mg/kg (FA-2); 500mg/kg (FA-3) groups. (a) Eﬀects in TC; (b) eﬀects in HDL-c; (c) eﬀects in LDL-c; (d) eﬀects in TG; (e) Eﬀects in
atherogenic index: (TC)−(HDL-c)/HDL-c. Each value represents mean± SE from six rats. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001 versus HCD
group.
Concentrations were determined from a standard curve by
using 1,1,3,3- tetraethoxypropane and was expressed as nmol
of malondialdehyde (MDA) formed per 100mg of tissue.
2.6. Statistical Analysis. All data presented are the mean ±
standard errors from three measurements. Statistical diﬀer-
ences were calculated using “Anova test”, followed by “Dun-
net Test”. Diﬀerences were considered significant at P < 0.05.
3. Results
3.1. Animal Weights and Food Intake. The weekly mean food
intake of the rats during the feeding period is showed in
Figure 1. There was a significant reduction in the food intake
in the groups treated with the highest and intermediate as-
paragus doses in respect to the hypercholesterolemic group.
It was also observed a tendency to reduce the body weight
in the asparagus-fed groups although the diﬀerences did not
reach significant values (Figure 2).
3.2. Plasma Lipid Profile and AtherogenicIndex (AI). Figure 3
shows the plasma lipid levels at the end of the experiment.
After five weeks of feeding, the plasmatic TC, TG, and LDL-c
concentrations of rats from HCD group showed a significant
increase compared with those of rats from SD group (P <
0.05; P < 0.01), and a decrease of HDL-c concentration in
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Figure 4: Eﬀects in liver index of rats from SD, HCD and
HCD supplemented with freeze-dried asparagus: 125mg/kg (FA-
1); 250mg/kg (FA-2); 500mg/kg (FA-3) groups. Liver index = liver
weight (g)/body weight (g) ×100. Each bar represents mean ± SE
from six rats. ∗∗∗P < 0.001 versus HCD group.
HCD group was also observed. Freeze-dried asparagus (FA)
was able to significantly reduce total cholesterol and LDL-
c levels (P < 0.01, P < 0.05, and P < 0.001) at doses of
500 and 250mg. In the HDL-c and TG levels, a beneficial
eﬀect was observed in the asparagus treated groups, although
these eﬀects were not significant. AI was reduced in a
dose-dependent manner by the administration of FA, being
significant at 250 and 500mg/Kg doses (P < 0.05, P < 0.01).
3.3. Changes in Liver Weights. Figure 4 shows the induced
changes in the liver weights in rats fed with cholesterol-
enriched diet compared to cholesterol-enriched and supple-
mented with FA. As it can be seen in Figure 4, FA treatments
were able to reduce the liver index (LI) or the weight of
this organ in respect to body weight. This reduction was
statistically significant at the higher dose (P < 0.001).
3.4. Antioxidant Status. SOD and CAT activities in the livers
are illustrated in Figure 5. The high dose of FA prevents
the reduction of both enzyme activities, SOD and CAT
induced by cholesterol rich diet, although only SOD activity
was significatively increased. As shown Figure 6, when MDA
levels of liver from rats HCD group were compared with
those obtained from SD group, a significant increase was
observed (P < 0.05) in this last group. Rats treated with
the highest dose of FA showed a significant decrease (P <
0.05) in the concentration of MDA measured in liver tissues
compared to those from hypercholesterolemic rats group.
4. Discussion
The present study was designed to evaluate the eﬀects of a
diet supplemented with green freeze-dried asparagus (FA)
from Andalusia (Spain) on plasma lipid levels and hepatic
antioxidant enzyme activities in hypercholesterolemic rats.
Rats fed a diet rich in cholesterol showed increased plasmatic
levels of TG, TC, and LDLc and decreased circulating HDLc,
thus providing a model for dietary hyperlipidemia studies
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Figure 5: Eﬀects on antioxidant enzymes of livers of rats from
SD, HCD, and HCD supplemented with freeze-dried asparagus:
125mg/kg (FA-1); 250mg/kg (FA-2); 500mg/kg (FA-3) groups. (a)
Superoxide dismutase activity (SOD); (b) Catalase activity (CAT).
Each bar represents mean ± SE from six rats. ∗∗P < 0.01 versus
HCD group.
[15]. Epidemiological studies indicate that supplemental
dietary fibre protects against the development of overweight,
which is an important cardiovascular risk factor widely
associated to high fat diets [16]. Our results showed a food
intake reduction in the group of animals treated with the
higher asparagus dose. This finding could be attributed to
the high-fibre content of this vegetable [17].
An increased concentration of serum cholesterol increas-
es the risk of developing cardiovascular disease [18]. After
treatment with FA for a period of 5 weeks, a significant
decrease in plasmatic TC accompanied by a reduction in its
LDLc fraction was observed in hyperlipidemic rats. LDLc
is a major risk factor in cardiovascular disease and is also
the target of many hypocholesterolaemic therapies. FA also
showed a beneficial eﬀect, causing a weak increase in HDL-c
level, although the diﬀerences were not statistically signifi-
cant. Similarly FA slightly decreased TG levels compared to
HCD group. Atherogenic index (AI) is considered to be an
important parameter of atherosclerosis. We found that HCD
group suﬀered a significant rise in AI compared to animals
from SD group, whereas the animals treated with FA (250
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Figure 6: Eﬀects on lipid peroxidation of livers of rats from
SD, HCD, and HCD supplemented with freeze-dried asparagus:
125mg/kg (FA-1); 250mg/kg (FA-2); 500mg/kg (FA-3). Each bar
represents mean ± SE from six rats. ∗P < 0.05; versus HCD group.
and 500mg/Kg) presented a decrease in this value. These data
indicates that the FA highest doses could eﬀectively improve
the plasmatic lipid profile. In this context, the presence
of bioactive components in “triguero asparagus,” such as
phytosterols, saponins, and fibre, may play a role in choles-
terol reduction, [16, 19, 20]. On the other hand, it is well
documented that high-cholesterol-rich diet can cause liver
damage by oxidation [21]. When rats are fed cholesterol-
rich diet, their livers, the primary organ that metabolizes
cholesterol ingested in excess, is aﬀected by oxidative stress
which leads to lipid peroxidation. In this study, oral admin-
istration of FA prevented the cholesterol-rich-diet-induced
MDA elevation. The treatment also resulted in a significant
decrease of liver MDA with the highest doses of FA, sug-
gesting that FA might be capable of attenuating or slowing
down oxidative stress-related lipid peroxidation.
It has been published that during oxidative stress tissues
respond by the induction of antioxidant mechanism [22].
However, in an excessive oxidative stress situation, the up-
regulation of defense system could not protect completely
against the oxidative damage produced by free radicals. In the
present study, we have observed decreased activities of anti-
oxidant enzymes SOD and CAT in the liver of rats fed on
HCD as compared to those on standard diet. Our results are
in agreement with reports of other workers, which suggest
that feeding an HCD to experimental animals depresses their
antioxidant system due to increased lipid peroxidation and
formation of free radicals [23]. The present study showed
that simultaneous treatment of cholesterol-fed rats with
doses of FA improved antioxidant defense, increasing SOD
and CAT activities. SOD activity was significantly increased
at the highest dose. These eﬀects could be attributed to a
protective antioxidant eﬀect produced by the high content
of flavonoids and other phenolic compounds of “trigu-
ero” asparagus, as it has already been described for other
flavonoid-rich plants [24].
In summary, this study shows that diet supplementation
with “triguero” asparagus is able to prevent atherogenic risk
markers as well as to prevent the oxidative hepatic damage
in hypercholesterolemic conditions. Likely, functional com-
ponents present in this asparagus variety, as flavonoids and
steroidal saponins, could be responsible, at least in part, for
this protective eﬀect.
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